It does two main things: first, it encourages insulin secretion in response to meals, which improves blood sugar control in patients with diabetes
In November 2023, the FDA approved tirzepatide for chronic weight management under the brand name Zepbound
The same principles apply to tirzepatide and retatrutide, though specific guidelines for retatrutide will not exist until it reaches the market
Researchers at the University of Pennsylvania used artificial intelligence to examine more than 400,000 Reddit posts and identify symptoms reported by patients taking GLP-1 drugs, including semaglutide and tirzepatide
But the good news is that even though it feels uncomfortable, it is usually very easy to manage
References Hamlet Gasoyan, Pfoh, E